Description of patients with eating disorders by general practitioners: a cohort study and focus on co-management with depression. [PDF]
Cadwallader JS +5 more
europepmc +1 more source
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source
The behavioral driving mechanism of ecological co-management among multiple subjects from the perspective of social network embedding: Evidence from coffee-producing areas in China. [PDF]
Xu X, Wang D.
europepmc +1 more source
The co-management of HIV and chronic non-communicable diseases in the Dominican Republic: A qualitative study. [PDF]
Wallace DD +6 more
europepmc +1 more source
Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock +4 more
wiley +1 more source
Surgical and Medical Co-Management in an 82-Year-Old Patient With Hemophilia a Undergoing Pancreaticoduodenectomy. [PDF]
Lu W, Liu C, He J, Cheng R.
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Patient and caregiver experiences of palliative care co-management in oncology. [PDF]
Brooks JV +4 more
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Orthogeriatric co-management and risk of rehospitalization in older patients with osteoporotic fractures: a retrospective cohort study from Germany. [PDF]
Unseld T +7 more
europepmc +1 more source

